MedTrace Logo

Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients

NCT06746571 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-12-24

No results posted yet for this study

Summary

Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Conditions

  • Lymphoblastic Leukemia

Interventions

DIAGNOSTIC_TEST

complete blood count

measure cbc and blood ratios to compare their values with respone of patients to treatment

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
5 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2026-01-15
Completion
2026-01-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06746571 on ClinicalTrials.gov